US Bancorp DE has sold 31.6% of its shares in Teladoc Health, Inc. (NYSE: TDOC), according to recent filings with the Securities and Exchange Commission. The firm now holds 38,299 shares of the company’s stock, valued at $992,000. Other institutional investors, including Forum Financial Management LP, Amalgamated Bank, Treasurer of the State of North Carolina, Canada Pension Plan Investment Board, and Mariner LLC, have also made changes to their holdings in Teladoc Health. These recent moves reflect the overall sentiment of institutional investors towards the stock.
Wall Street analysts have given mixed views on Teladoc Health, with one rating the stock as a sell, ten as hold, and six as buy. The average price target for the stock, according to MarketBeat, is $31.20.
Teladoc Health is a provider of virtual healthcare services and operates in two segments: Integrated Care and BetterHelp. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enterprise telehealth solutions for hospitals and health systems.
In recent news, Teladoc Health CEO Jason N. Gorevic sold 10,000 shares of the company’s stock at an average price of $30.03. Gorevic now holds 596,246 shares valued at $17,905,267.38. Company insider Claus Torp Jensen also sold 6,547 shares at an average price of $29.00.
Teladoc Health has a market capitalization of $3.77 billion and a price-to-earnings (P/E) ratio of -0.92. The stock has a 52-week low of $21.60 and a 52-week high of $35.31. The company reported earnings per share of ($0.40) for the most recent quarter, beating the consensus estimate of ($0.44).
Source: claytoncountyregister.com
